Molecular pathogenesis and diagnostics of bladder cancer

AP Mitra, RJ Cote - Annual Review of Pathology: Mechanisms of …, 2009 - annualreviews.org
Despite elaborate characterization of the risk factors, bladder cancer is still a major
epidemiological problem whose incidence continues to rise each year. Urothelial carcinoma …

A systematic review of the diagnostic and prognostic value of urinary protein biomarkers in urothelial bladder cancer

JJ D'Costa, JC Goldsmith, JS Wilson… - Bladder …, 2016 - content.iospress.com
For over 80 years, cystoscopy has remained the gold-standard for detecting tumours of the
urinary bladder. Since bladder tumours have a tendency to recur and progress, many …

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

VB Lokeshwar, T Habuchi, HB Grossman, WM Murphy… - Urology, 2005 - Elsevier
This is the first of 2 articles that summarize the findings of the International Consensus Panel
on cytology and bladder tumor markers. The objectives of our panel were to reach a …

High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer

W Yi, E Xiao, R Ding, P Luo… - Oncology reports, 2016 - spandidos-publications.com
Fibronectin is a glycoprotein of the extracellular matrix, and regulates the processes of self-
renewal and cell cycle progression. This study aimed to investigate fibronectin expression in …

[HTML][HTML] Biomarkers for bladder cancer management: present and future

F Ye, L Wang, M Castillo-Martin, R McBride… - American journal of …, 2014 - ncbi.nlm.nih.gov
Accurate and sensitive detection of bladder cancer is critical to diagnose this deadly disease
at an early stage, estimate prognosis, predict response to treatment, and monitor recurrence …

Urinary schistosomiasis and the associated bladder cancer: update

MS Zaghloul, TM Zaghloul, MK Bishr… - Journal of the Egyptian …, 2020 - Springer
Background Urinary schistosomiasis and its severe complications, mainly bladder cancer,
are scarce in non-endemic areas. The deficiency in knowledge and clinical experience of …

Molecular markers in bladder cancer: a critical appraisal

BR Konety - Urologic Oncology: Seminars and original …, 2006 - Elsevier
The diagnosis of both primary and recurrent bladder tumors currently relies upon the urine
cytology and cystoscopy. Neither of these diagnostic tools is completely accurate …

Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia

S Babu, DC Mockler, L Roa-Peña, A Szygalowicz… - Modern …, 2019 - nature.com
There is a clinical need to identify novel biomarkers to improve diagnostic accuracy for the
detection of urothelial tumors. The current study aimed to evaluate keratin 17 (K17), an …

Urinary markers of bladder carcinoma

P Dey - Clinica chimica acta, 2004 - Elsevier
Purpose: Transitional cell carcinoma of bladder is one of the most common tumors of
genitourinary tract. Cystoscopy along with cytology is the mainstay for diagnosing bladder …

Molecular screening for bladder cancer: progress and potential

AP Mitra, RJ Cote - Nature Reviews Urology, 2010 - nature.com
Carcinoma of the urinary bladder is a common malignancy and a major cause of morbidity
and mortality in the western world. Current understanding of etiology, disease process …